|
[1]Stoll-Keller F, Barth H, Fafi-Kremer S, et al.Developmentof hepatitis C virus vaccines:challenges and progress[J].Expert Rev Vaccines, 2009, 8 (3) :333-345.
|
|
[2]Yerly D, Heckerman D, Allen TM, et al.Increased cytotoxicT-lymphocyte epitope variant cross-recognition andfunctional avidity are associated with hepatitis C virusclearance[J].J Virol, 2008, 82 (6) :3147-3153.
|
|
[3]Takao Y, Yamada A, Yutani S, et al.Identification of newimmunogenic peptides in conserved regions of hepatitisC virus (HCV) 1b with the potentiality to generatecytotoxic T lymphocytes in HCV1b (+) HLA-A24 (+) patients[J].Hepatol Res, 2007, 37 (3) :186-195.
|
|
[4]Vider-Shalit T, Raffaeli S, Louzoun Y.Virus-epitopevaccine design:informatic matching the HLA-Ipolymorphism to the virus genome[J].Mol Immunol, 2007, 44 (6) :1253-1261.
|
|
[5]Shi L, Liu S, Fan GX, et al.Effective induction of type1 cytotoxic T cell responses in mice with DNA vaccineencoding two hepatitis C virus cytotoxic T lymphocyteepitopes[J].Viral Immunol, 2006, 19 (4) :702-711.
|
|
[6]Chang KM, Gruener NH, Southwood S, et al.Identification of HLA-A3 and-B7-restricted CTLresponse to hepatitis C virus in patients with acute andchronic hepatitis C[J].J Immunol, 1999, 162 (2) :1156-1164.
|
|
[7]Sallberg M, Zhang ZX, Chen M, et al.Immunogenicityand antigenicity of the ATPase/helicase domain of thehepatitis C virus non-structural 3 protein[J].J Gen Virol, 1996, 77 (Pt11) :2721-2728.
|
|
[8]Sarobe P, Lasarte JJ, García N, et al.Characterizationof T-cell responses against immunodominant epitopesfrom hepatitis C virus E2 and NS4a proteins[J].J ViralHepat, 2006, 13 (1) :47-55.
|
|
[9]李端, 谢玉梅, 薛小平, 等.中国丙型肝炎病毒细胞毒性T淋巴细胞表位预测及其多表位疫苗设计[J].中华肝脏病杂志, 2009, l7 (10) :786-787.
|
|
[10]Hurwitz JL, Zhan X, Brown SA, et al.HIV-1 vaccinedevelopment:tackling virus diversity with a multi-envelope cocktail[J].Front Biosci, 2008, 13:609-620.
|
|
[11]Yerly D, Heckerman D, Allen T, et al.Design, expression, and processing of epitomized hepatitis C virus-encodedCTL epitopes[J].J Immunol, 2008, 181 (9) :6361-6370.
|
|
[12]Koh S, Bertoletti A.Viral hepatitis and serotonin:alteringcytotoxic T-lymphocyte function in the liver[J].ExpertRev Vaccines, 2009, 8 (1) :29-32.
|
|
[13]Encke J, Radunz W, Eisenbach C, et al.Development of aheterologous, multigenotype vaccine against hepatitis Cvirus infection[J].Eur J Clin Invest, 2007, 37 (5) :396-406.
|
|
[14]Azizi A, Diaz-Mitoma F.Viral peptide immunogens:current challenges and opportunities[J].J Pept Sci, 2007, 13 (12) :776-786.
|
DownLoad: